Has Dicken Ko, MD received payments from drug or device companies?

Yes. Drug and device makers reported $158,128 in general payments to Dicken Ko, MD across 136 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dicken Ko, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dicken Ko, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dicken Ko, MD

Urology · Providence, RINPI 1083604219

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (57.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 53.0% of the total. 2025 is the largest year on record at $52,665, more than ten times the $439 reported in 2019. Among urology clinicians in RI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$158,128in general payments, 2019–2025

Across 136 payments — averaging $1162.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$84K
Sanofi-aventis U.S. LLC$55K
Sanofi$12K
Gyrus ACMI, Inc.$4K
Medtronic$1K
Boston Scientific$299
plus $1K from 14 others

What the payments were for

Consulting fees$91,28858%
Speaking & faculty fees$49,85532%
Travel & lodging$12,3268%
Food & beverage$4,6583%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker	76	$83,858
Sanofi-aventis U.S. LLC	27	$54,900
Sanofi	3	$11,964
Gyrus ACMI, Inc.	4	$4,250
Medtronic	2	$1,438
Boston Scientific	5	$299
Veloxis Pharmaceuticals, Inc.	2	$230
ZOLL Medical Corporation	1	$175
Angiodynamics, Inc.	1	$166
Teleflex LLC	2	$162
Olympus America Inc.	2	$132
Intuitive Surgical	2	$128
Steris Corporation	1	$123
Amgen	2	$121
Neotract Inc.	1	$45
Johnson & Johnson	1	$41
Astellas Pharma US Inc	1	$40
Metuchen Pharmaceuticals	1	$22
Dentsply IH Inc.	1	$20
Axonics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

THYMOGLOBULIN$54,701
1788$22,733
S3$12,000
Iris$11,206
1688$9,400
SPY-PHI SYSTEM$4,497
Soltive$2,675
MEDICAL CONTROL UNIT FOR ENDOSURGERY UCES-4$1,575
FLUID SAFE$500
NA$500
Envarsus$230
Defibrillator$175
Nanoknife$166
UroLift System$146
TRITANIUM$144
Uretero1$123
REZUROCK$120
1588$114
AMS$106
Parsabiv$104

How this compares

$158,128 in reported general payments places this provider in the 95th percentile of 55 urology providers in Rhode Island.

See all urology providers in Rhode Island →

Medicare billing

Part B allowed, 2024

$33,688

Medicare patients

141

Services billed

418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Tamsulosin Hcl	190	$2,548
Finasteride	200	$2,235
Silodosin	11	$566
Oxybutynin Chloride	11	$157
Alfuzosin Hcl ErAlfuzosin Hcl	13	$103
Ciprofloxacin Hcl	20	$64

Paid to pharmacies, not to this prescriber.

Other urology in Providence

Gyan PareekProvidence$83K
Joseph RenzulliProvidence$81K
Simone ThavaseelanProvidence$16K
Boris GershmanProvidence$13K
Janice Santos CortesProvidence$12K
Dragan GolijaninProvidence$11K
Elias HyamsProvidence$10K
Andrew TompkinsProvidence$3K
Ashley MatthewProvidence$3K
Gabriella AvellinoProvidence$2K

See the full list for Rhode Island →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →